As of 1:39pm ET
| +0.10 / +0.94%|
The 5 analysts offering 12-month price forecasts for Avadel Pharmaceuticals PLC have a median target of 16.00, with a high estimate of 27.00 and a low estimate of 13.00. The median estimate represents a +48.29% increase from the last price of 10.79.
The current consensus among 5 polled investment analysts is to Buy stock in Avadel Pharmaceuticals PLC. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.